Connection
Kian Behbakht to Bevacizumab
This is a "connection" page, showing publications Kian Behbakht has written about Bevacizumab.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.029 |
|
|
|
-
Hensley ML, Miller A, O'Malley DM, Mannel RS, Behbakht K, Bakkum-Gamez JN, Michael H. Randomized phase III trial of gemcitabine plus docetaxel plus bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma: an NRG Oncology/Gynecologic Oncology Group study. J Clin Oncol. 2015 Apr 01; 33(10):1180-5.
Score: 0.029